StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker U.S. MedTech Industry Total by Quarter

U.S. MedTech Industry Total — FDA 510(k) Clearances (clearances)

QuarterlyAnnualMonthly

Stryker U.S. MedTech Industry Total: 855 in Q3 2026, up 7.3% from a year earlier.

Latest, Q3 2026
855
Period ended Sep 30, 2026
Change on a year earlier
+7.3%
797 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker

Where the Q3 2026 figure comes from

Source: U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. MedTech Industry Total — FDA 510(k) Clearances (clearances)Year on yearSource
Q3 2026Sep 30, 2026855+7.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2026Jun 30, 2026923+4.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2026Mar 31, 2026756+2.7%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2025Dec 31, 2025806-5.8%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2025Sep 30, 2025797+3.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2025Jun 30, 2025886+11.7%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2025Mar 31, 2025736+3.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2024Dec 31, 2024856-2.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2024Sep 30, 2024767-13.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2024Jun 30, 2024793-2.0%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2024Mar 31, 2024713-8.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2023Dec 31, 2023877+2.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2023Sep 30, 2023883+11.3%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2023Jun 30, 2023809-2.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2023Mar 31, 2023777+6.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2022Dec 31, 2022857+6.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Cite this data

StockData. (2026). Stryker U.S. MedTech Industry Total, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ext-fda-510k-ind

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.